Hookipa Pharma Inc
General ticker "HOOK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $29.0M
Hookipa Pharma Inc does not follow the US Stock Market performance with the rate: -33.5%.
Estimated limits based on current volatility of 4.7%: low 1.91$, high 2.09$
Factors to consider:
- Current price 50.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.14$, 11.30$]
- 2024-12-30 to 2025-12-30 estimated range: [3.81$, 10.17$]
Financial Metrics affecting the HOOK estimates:
- Negative: Non-GAAP EPS, $ of -7.70 <= 0.10
- Negative: Operating profit margin, % of -82.92 <= 1.03
- Negative: Operating cash flow per share per price, % of -49.56 <= 2.35
- Negative: negative Net income
- Negative: Inventory ratio change, % of 10.03 > 1.08
- Positive: -0.96 < Investing cash flow per share, $ of -0.44
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term HOOK quotes
Long-term HOOK plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $18.45MM | $14.25MM | $20.13MM |
| Operating Expenses | $100.12MM | $87.40MM | $117.82MM |
| Operating Income | $-81.67MM | $-73.16MM | $-97.69MM |
| Non-Operating Income | $6.01MM | $8.47MM | $16.48MM |
| Interest Expense | $0.90MM | $0.00MM | $0.32MM |
| R&D Expense | $82.85MM | $68.64MM | $86.42MM |
| Income(Loss) | $-75.66MM | $-64.69MM | $-81.21MM |
| Taxes | $0.00MM | $0.23MM | $0.37MM |
| Profit(Loss) | $-75.67MM | $-64.92MM | $-81.58MM |
| Stockholders Equity | $89.59MM | $102.52MM | $89.86MM |
| Inventory | $15.26MM | $0.42MM | $0.00MM |
| Assets | $126.05MM | $170.45MM | $161.34MM |
| Operating Cash Flow | $-66.02MM | $-20.00MM | $-57.52MM |
| Capital expenditure | $12.58MM | $5.02MM | $4.16MM |
| Investing Cash Flow | $-12.58MM | $-5.02MM | $-4.16MM |
| Financing Cash Flow | $-0.23MM | $72.27MM | $65.67MM |
| Earnings Per Share* | $-23.00 | $-9.90 | $-8.63 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.